Monopar Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNPR and other ETFs, options, and stocks.

About MNPR

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. 

CEO
Chandler Drew Robinson
CEOChandler Drew Robinson
Employees
10
Employees10
Headquarters
Wilmette, Illinois
HeadquartersWilmette, Illinois
Founded
2014
Founded2014
Employees
10
Employees10

MNPR Key Statistics

Market cap
11.49M
Market cap11.49M
Price-Earnings ratio
-1.08
Price-Earnings ratio-1.08
Dividend yield
—
Dividend yield—
Average volume
78.84K
Average volume78.84K
High today
$0.679
High today$0.679
Low today
$0.63
Low today$0.63
Open price
$0.63
Open price$0.63
Volume
35.01K
Volume35.01K
52 Week high
$1.75
52 Week high$1.75
52 Week low
$0.2739
52 Week low$0.2739
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.